Margaret Camarca

Overview

Margaret Camarca, RN, MPH, is a Senior Research Associate with 30 years of clinical and research experience. She is the project director for Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone project. In addition, she supports the Cancer Trials Support Unit by conducting national coverage analyses to assess financial liability issues for NCI-sponsored research protocols. She has served as the study manager and analyst for various projects including a phase III study assessing three antiretroviral postpartum regimens for prevention of intrapartum HIV-1, an NIAID-sponsored phase I gene transfer study for X-linked Severe Combined Immunodeficiency, establishment of a biospecimen repository in India through the NIAID’s Indo-U.S. Vaccine Action Program Initiative on Tuberculosis, and DAIDS-supported studies assessing clinical factors influencing the shedding of HIV-1 in cervicovaginal secretions.

In earlier work, Camarca served as the full-time volunteer pharmacist at a tertiary care facility serving approximately 500,000 impoverished inhabitants in Sudan and as the principal investigator for a descriptive study of tuberculosis among active-duty Army personnel.

Education

• MPH (summa cum laude), Tropical Public Health Tract, Uniformed Services University of the Health Sciences
• BSN (cum laude), University of Texas, Arlington
• BS (magna cum laude), Biology, Virginia Polytechnic Institute and State University